Evidence map›Paper›PMID 25402006›Full record

ArticleNature methods2015

In silico prediction of physical protein interactions and characterization of interactome orphans.

Max Kotlyar, Chiara Pastrello, Flavia Pivetta, Alessandra Lo Sardo, Christian Cumbaa, Han Li, Taline Naranian, Yun Niu, Zhiyong Ding, Fatemeh Vafaee and 7 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Nature methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. ARL6IP1 mediates small-molecule-induced alleviation of Alzheimer pathology through FXR1-dependent BACE1 translation initiation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. ProtInteract: A deep learning framework for predicting protein-protein interactions.Computational and structural biotechnology journal · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.Journal of cellular and molecular medicine · 2022
    Review
  16. Article
  17. Article
  18. Deep learning frameworks for protein-protein interaction prediction.Computational and structural biotechnology journal · 2022
    Review
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Max KotlyarPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Chiara Pastrello1] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. [2] Centro Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy.
Flavia PivettaCentro Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy.
Alessandra Lo SardoCentro Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy.
Christian CumbaaPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Han LiLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Taline NaranianLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Yun Niu1] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. [2] Nanjing University of Aeronautics and Astronautics, Nanjing, China.
Zhiyong DingDepartment of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fatemeh Vafaee1] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. [2] Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Fiona Broackes-CarterPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Julia PetschniggDonnelly Centre, Departments of Molecular Genetics and Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Gordon B MillsDepartment of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andrea JurisicovaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Igor StagljarDonnelly Centre, Departments of Molecular Genetics and Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Roberta MaestroCentro Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy.
Igor Jurisica1] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. [3] Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. [4] TECHNA Institute for the Advancement of Technology for Health, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre · CACentro di Riferimento Oncologico · ITUniversity of Toronto · CAMount Sinai Hospital · CAThe University of Texas MD Anderson Cancer Center · USUniversity Health Network · CALunenfeld-Tanenbaum Research Institute · CA

Funding

The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
Tyrosine Kinase-Dependant and - Independent Pathways of EGFR in Breast Cancer ProP01CA099031 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUNG, MIEN-CHIE · 2003 to 2014
$11.6M
Effective Mammalian Two Hybrid Screening ApproachR21CA126700 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DING, ZHIYONG · 2007 to 2008
$381k
Canadian Institutes of Health Research #93579Canadian Institutes of Health Research #99745Canadian Institutes of Health Research NHG99091Canadian Institutes of Health Research PPP-125785NCI NIH HHS 01CA0099031NCI NIH HHS NCI R21 CA126700NHGRI NIH HHS R01 HG001715
6 · The paper itself

Abstract

Protein-protein interactions (PPIs) are useful for understanding signaling cascades, predicting protein function, associating proteins with disease and fathoming drug mechanism of action. Currently, only ∼ 10% of human PPIs may be known, and about one-third of human proteins have no known interactions. We introduce FpClass, a data mining-based method for proteome-wide PPI prediction. At an estimated false discovery rate of 60%, we predicted 250,498 PPIs among 10,531 human proteins; 10,647 PPIs involved 1,089 proteins without known interactions. We experimentally tested 233 high- and medium-confidence predictions and validated 137 interactions, including seven novel putative interactors of the tumor suppressor p53. Compared to previous PPI prediction methods, FpClass achieved better agreement with experimentally detected PPIs. We provide an online database of annotated PPI predictions (http://ophid.utoronto.ca/fpclass/) and the prediction software (http://www.cs.utoronto.ca/~juris/data/fpclass/).

Indexed as

Computer SimulationComputational BiologyData MiningHumansProtein Interaction MappingProteomeSoftwareTumor Suppressor Protein p53ProteomeTumor Suppressor Protein p53

Identifiers

PMID25402006
OpenAlexW1999586982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.